Income Statement
MUSTANG BIO, INC.
MBIO
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY |
|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - | - | - | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - | - | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - | - | - | - | - | - |
|
Operating Expenses
|
2.43 | 16.25 | 49.26 | 76.16 | 66.72 | 56.81 | 45.89 | 31.22 | 31.79 | 11.36 |
|
Research & Development
|
- | 7.56 | 40.51 | 62.48 | 49.86 | 37.24 | 30.04 | 21.10 | 7.94 | 2.47 |
|
Selling, General & Administrative
|
3.95 | 4.14 | 9.69 | 12.21 | 11.02 | 9.51 | 9.57 | 6.76 | 11.41 | 2.82 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-2.43 | -16.25 | -49.26 | -76.16 | -66.72 | -56.81 | -45.89 | -31.22 | -31.79 | -11.36 |
|
Non-Operating Income
|
0.51 | 0.49 | -2.34 | -1.37 | 0.35 | -3.21 | -0.50 | 0.56 | 0.50 | -1.29 |
|
Interest Income
|
0.51 | 0.18 | 0.85 | 0.69 | - | 0.71 | 1.26 | 0.57 | 0.51 | 0.02 |
|
Interest Expense
|
- | 0.01 | 4.11 | 3.36 | - | 3.92 | 1.77 | 0.01 | 0.01 | 0.90 |
|
Other Non-Op Income / Expense
|
- | 0.31 | - | - | - | - | - | - | - | - |
|
Income Before Tax
|
-1.92 | - | - | - | - | - | - | - | - | - |
|
Income Tax Expense
|
0.00 | - | - | - | - | - | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - | - |
|
Net Income
|
-1.92 | -15.75 | -51.60 | -77.53 | -66.37 | -60.02 | 0.00 | 0.00 | 0.00 | 0.00 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY |
|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-2.43 | -16.25 | -49.26 | -76.16 | -66.72 | -56.81 | -45.89 | -31.22 | -31.79 | -11.36 |
|
Earnings Per Share (Basic)
|
-0.39 | -38.57 | -6.00 | -0.75 | - | - | - | - | - | - |
|
Diluted EPS
|
-0.39 | -38.57 | -6.00 | -0.75 | - | - | - | - | - | - |
|
Weighted Average Shares
|
4.91 | 0.61 | 8.60 | 103.43 | - | - | - | - | - | - |
|
Diluted Weighted Avg Shares
|
4.91 | 0.61 | 8.60 | 103.43 | - | - | - | - | - | - |
|
Comprehensive Income
|
- | - | - | - | - | - | - | - | - | - |